PurpleLab Raises $40M Series B from Primus Capital


Series B Round to Accelerate PurpleLab’s Investment in Real-World Evidence Solutions Built on the Company’s HealthNexus™ Platform

PurpleLab, Inc.  announced a $40 million Series B funding round led by Primus Capital, which joins existing investor Edison Partners. TripleTree served as the exclusive financial advisor to PurpleLab for this transaction. The investment highlights PurpleLab’s growing role in simplifying the access to and interpretation of Real-World Data (RWD) across the healthcare continuum.

PurpleLab has experienced triple-digit growth[KV1]  for four consecutive years. This additional funding will enable the company to continue its growth trajectory and accelerate investments in new data assets, product development, and human capital. Stakeholders across the healthcare industry are using PurpleLab’s RWD infrastructure to reduce time to insights while simultaneously improving cost efficiencies.

“We’re laser-focused on creating infrastructure and tools to assist our clients in converting real-world data into real-world evidence and this investment will accelerate the rate of adoption, conversion, and ultimate return on their investment,” commented Mark Brosso, CEO and Founder of PurpleLab. “Understanding comparative performance of various treatments for every condition is becoming easier through technologies such as deidentification via tokenization and is being further driven by legislative mandates such as the 21st Century Cures Act. In a world with increased access to RWD, the biggest challenge lies in the ability to readily interpret the data. PurpleLab’s HealthNexus™ platform was designed to solve this problem and we are thrilled that Primus shares our vision.”

Phil Molner, Managing Partner of Primus Capital, stated “Through its HealthNexus platform, PurpleLab has successfully organized and deployed real-world data to bring differentiated yet rapid commercial and clinical insights to the life sciences industry. We are excited to work with an industry leader like Mark Brosso and the rest of the PurpleLab team to continue to build upon the company’s success to date.”

“PurpleLab has established itself as an industry leader through a differentiated data and analytics platform along with rapid, consistent growth since our initial investment in 2020,” said Gregg Michaelson, General Partner, Edison Partners. “We are thrilled to continue supporting Mark and the entire PurpleLab team through this next phase of growth.”

Founded in 2017, PurpleLab has a strong pedigree in proprietary methodologies for data organization, cleansing, management, and governance to solve key challenges across the healthcare industry. PurpleLab continues to be recognized as a leading expert in the RWD space and was recently awarded Qualified Entity certification status by The Centers for Medicare and Medicaid Services (CMS).